论文部分内容阅读
(本刊讯)为了使业务重心不仅仅专注于活性医药成分市场,瑞士龙沙集团2011年7月15日宣布,将以14亿美元现金收购美国专用化学品企业奥麒公司。购并完成后,龙沙在继续保持定制化学品领域领先地位,还将在规模达100亿美元的全球抗菌产品市场占15%的份额。龙沙集团是以生命科学为导向的化工及生物技术公司,旗下20多家生产厂和研发中心遍布全球各地,在生产和支持医药活性成分方面居世界领先地位,2010年销售额约为29亿美元。奥麒化工有
(Ben Kanxun) In order to focus not only on the active pharmaceutical ingredient market, the Swiss Longsha Group announced on July 15, 2011 that it will acquire US specialty chemicals company Oki for 1.4 billion U.S. dollars in cash. After the completion of the acquisition, Lonza continues to maintain its leading position in the field of custom chemicals and will also account for 15% of the global antibacterial product market with a total value of 10 billion U.S. dollars. Lonza Group is a life science-oriented chemical and biotechnology company with more than 20 manufacturing plants and R & D centers around the world, leading the world in the production and support of pharmaceutical active ingredients with 2010 sales of approximately 2.9 billion Dollars. Ok Yee chemical there